Pharmaceutical Continuous Manufacturing Market Driven By Munson Machinery, Fette Compacting, Alexanderwerk, Hovioneen Aesica, Munson Machinery

The pharmaceutical continuous manufacturing market is expected to reach US$ 3,064.38 million by 2027 from US$ 1,459.53 million in 2019. The market is estimated to grow at a CAGR of 9.8% from 2020 to 2027.

Continuous manufacturing in the pharmaceuticals industry is a result of advancements in technology with respect to the production techniques. In the past years, the traditional method of batch manufacturing was followed in the pharmaceuticals industry. However, the development in technology has accelerated mass production with improved quality, and it has addressed many primary issues such as the recall of drugs. The pharmaceuticals industry has recently begun to acknowledge the continuous manufacturing as an option to improve and sustain manufacturing operations.

Get Sample Report + All Related Graphs & Charts @  https://www.theinsightpartners.com/sample/TIPRE00008245/

The pharmaceutical continuous manufacturing market majorly consists of the players such as GEA Group, Coperion GmbH, Gericke AG, Glatt GmbH, Hosokawa Micron Group, Munson Machinery Co. Inc., Powrex Corp, Thermo Fisher Scientific Inc., Freund-vector Corporation, Fette Compacting, Alexanderwerk, LEISTRITZ AG, KORSCH AG, ACG, Cadmach Machinery Co. Pvt. Ltd., and Hovione en Aesica.

The companies are focused toward the adoption of organic strategies such as partnership and collaborations to sustain their position in the dynamic market. For instance, in January 2017, GEA has entered into a partnership with Siemens AG to the pharmaceutical and life sciences industry by offering an integrated continuous tablet manufacturing line.

The pharmaceutical continuous manufacturing market, by product, is segmented into screening and diagnostics, monitoring and alerting and disease management. In 2019, the integrated systems segment accounted for the largest market share of the global pharmaceutical continuous manufacturing market. The integrated systems are expected to dominate the product segment owing to their easy availability and accessibility as well as higher adoption of these systems as compared with the semi-continuous systems and the controls. The integrated systems help build the continuous flow during manufacturing process, facilitate end-to-end integration, and improve asset utilization.

The increasing shortages of drugs and APIs in various parts of the world coupled with advantages offered by continuous manufacturing systems in ramping up the production volumes, reducing the drug costs are expected to be the major driving factors of the market. However, deep penetration of batch manufacturing systems and high capital investments for these systems are expected to restrain the growth of the market to an extent.

The Food and Drug Administration (FDA) states that the reasons for drug shortages occur for various reasons including quality problems, manufacturing inefficiency, delays, and discontinuations. The drugs that are often short in supply include sterile injectable and oncology/cancer treatments. The notice from manufacturers to the FDA regarding the impending or current shortages of drugs allows the FDA to work with the manufacturers over finding feasible solutions, one of which is usually ramping up the manufacturing of drugs through implementation of new and advanced systems such as continuous manufacturing.

The scenario of drug shortage is also prevalent in the European countries. For instance, according to a report published by The Economist Intelligence Unit Limited in 2017, the prevalence of medicine shortage was highin Europe. The three major causes determined for the shortage included manufacturing, economic and regulatory causes. Thus, to meet the rising demand for biologics and drugs and to curb the lack of drug availability, pharmaceutical continuous manufacturing market holds a promising growth scenario.

To comprehend Global Pharmaceutical Continuous Manufacturing market dynamics in the world mainly, the worldwide Pharmaceutical Continuous Manufacturing market is analyzed across major global regions.

• North America: United States, Canada, and Mexico.
• South & Central America: Argentina, Chile, and Brazil.
• Middle East & Africa: Saudi Arabia, UAE, Turkey, Egypt and South Africa.
• Europe: UK, France, Italy, Germany, Spain, and Russia.
• Asia-Pacific: India, China, Japan, South Korea, Indonesia, Singapore, and Australia.

Purchase Full Copy of This Report @ https://www.theinsightpartners.com/buy/TIPRE00008245/ 

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:

Call: +1-646-491-9876

Email: sales@theinsightpartners.com